MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Discover Blood Group Waldner Type, its diagnosis through blood tests, and the benefits of genetic testing in identifying carriers, informing treatment decisions, and family…
Discover the importance of the Wright antigen in blood group disorders and how genetic testing plays a crucial role in diagnosing and managing these conditions.
Discover the role of QTL1 in bone mineral density, osteoporosis risk, and how genetic testing can lead to early diagnosis, personalized treatment, and better bone health.
Discover the role of genetic testing in understanding Brain Tumor-Polyposis Syndrome 2, its diagnosis, treatment, and family planning decisions.
Discover Greig cephalopolysyndactyly syndrome (GCPS), a rare genetic disorder causing hand & foot malformations. Learn the importance of genetic testing for diagnosis & management.
Discover the importance of genetic testing in diagnosing and managing Butyrylcholinesterase deficiency, including the fluoride-resistant Japanese type, for personalized treatment…
Discover the role of genetic testing in diagnosing and treating nonprogressive cardiac conduction defects, enabling personalized care and improved health outcomes.
Discover the role of genetic testing in diagnosing Cataract 38, understanding Epha2 gene's influence, and creating personalized treatment plans for improved vision.